Steven Cohen's MRVI Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 2.85 M shares of Maravai LifeSciences Holdings, Inc. (MRVI) worth $9.26 M, representing 0.01% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in MRVI, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 2.82 M shares. Largest reduction occurred in Q3 2024, reducing 2.49 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Maravai LifeSciences Holdings (MRVI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Maravai LifeSciences Holdings (MRVI) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2.82 M | Add 8597.69% | 2.85 M | $3.25 |
| Q3 2025 | +32,742 | New Buy | 32,742 | $2.87 |
| Q4 2024 | -1.03 M | Sold Out | 0 | $0.00 |
| Q3 2024 | -2.49 M | Reduce 70.83% | 1.03 M | $8.31 |
| Q2 2024 | +2.11 M | Add 149.55% | 3.52 M | $7.16 |
| Q1 2024 | +459,162 | Add 48.27% | 1.41 M | $8.67 |
| Q4 2023 | +951,200 | New Buy | 951,200 | $6.55 |
| Q3 2023 | -460,111 | Sold Out | 0 | $0.00 |
| Q2 2023 | +460,111 | New Buy | 460,111 | $12.43 |
| Q4 2022 | -151,000 | Sold Out | 0 | $0.00 |
| Q3 2022 | +151,000 | New Buy | 151,000 | $25.53 |
| Q1 2022 | -390,900 | Sold Out | 0 | $0.00 |
| Q4 2021 | +261,412 | Add 201.88% | 390,900 | $41.90 |
| Q3 2021 | +129,488 | New Buy | 129,488 | $49.08 |
| Q1 2021 | -493,883 | Sold Out | 0 | $0.00 |
| Q4 2020 | +493,883 | New Buy | 493,883 | $28.05 |
Steven Cohen's Maravai LifeSciences Holdings Investment FAQs
Steven Cohen first purchased Maravai LifeSciences Holdings, Inc. (MRVI) in Q4 2020, acquiring 493,883 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Maravai LifeSciences Holdings, Inc. (MRVI) for 16 quarters since Q4 2020.
Steven Cohen's largest addition to Maravai LifeSciences Holdings, Inc. (MRVI) was in Q4 2025, adding 2,847,799 shares worth $9.26 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 2,847,799 shares of Maravai LifeSciences Holdings, Inc. (MRVI), valued at approximately $9.26 M.
As of the Q4 2025 filing, Maravai LifeSciences Holdings, Inc. (MRVI) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Maravai LifeSciences Holdings, Inc. (MRVI) was 3,519,561 shares, as reported at the end of Q2 2024.